Tech Company Financing Transactions
Eton Pharmaceuticals Funding Round
Private investors invested in a $20 million Series A funding round for Eton Pharmaceuticals. The funding round was announced by the company on 6/21/2017.
Transaction Overview
Company Name
Announced On
6/21/2017
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series A
Investors
Proceeds Purpose
Eton will use the proceeds of the financing to develop its patent-pending sterile injectable drug candidate pipeline, as well as for general corporate purposes.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
21925 W Field Pkwy. 235
Deer Park, IL 60010
USA
Deer Park, IL 60010
USA
Phone
Website
Email Address
Overview
Eton Pharmaceuticals, Inc., a privately held company, is focused on the development and commercialization of innovative sterile injectable product candidates utilizing the FDA 505(b)(2) regulatory pathway.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sean Brynjelsen
Chief Financial Officer
Wilson Troutman
VP - Bus. Development
David Krempa
VP - Regulatory Affairs
Bharathi Devarakonda
VP - Sales
Scott Grossenbach
VP - Sales
Brian Hills
Browse more venture capital transactions:
Prev: 6/21/2017: CirrusMD venture capital transaction
Next: 6/21/2017: CloudPost Networks venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC transactions on this site are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs